The women’s health market continues to see unprecedented competition for transactions. These trends, along with COVID-19-specific transaction considerations, create interesting dynamics for investors and providers in the...more
RiverVest Venture Partners has announced it has closed its fifth fund — RiverVest Venture Fund V — with $275 million of capital commitments....more
NRD Capital Management has announced a growth capital investment in FundRx.
The investment was made through NRD’s affiliate NRD Healthcare Solutions....more
Intelligent Retinal Imaging Systems (IRIS) has announced it has successfully closed a round of Series B financing.
IRIS, based in Pensacola, Fla., is a developer of early detection systems for diabetic eye disease....more
OrbiMed has announced the closing of its next venture capital fund with $950 million in limited partner commitments.
OrbiMed, headquartered in New York City, is an investment firm dedicated to the healthcare sector, with...more
Metacrine, based in San Diego, Calif., is a biotechnology company focused on advancing research in nuclear hormone receptors for treatment of metabolic diseases originated at the Salk Institute for Biological Studies....more
The firm indicated the new fund will invest in advancements in science that may lead to therapeutic interventions in genetic diseases, cancer and orphan diseases, as well as back new technologies focused on the development of...more